YHYogesh Hooda

Yogesh Hooda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yogesh Hooda has a total of 272 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Capsule-independent bacteriophages reveal unexpected diversity of Salmonella Typhi phage ecology

    by Shantu Dey, Shuborno Islam, Al Amin, Mohammad Daniyal Karim, Sadnane Hussain Pranto, Rathindranath Kabiraj, Neoyman Nasir, Hakka Naziat, Arif M Tanmoy, Samir K Saha, et al.

    Bacteriophages that infect Salmonella enterica serovar Typhi ( S. Typhi), the cause of typhoid fever, are regarded as specialized, because all previously characterized phages depend on the Vi capsular polysaccharide for infection. Whether capsule-independent infection strategies exist has remained unclear. Here we identify environmental phages that infect S. Typhi both in the presence and absence of Vi. Screening 140 urban wastewater samples from Dhaka, Bangladesh, where typhoid is endemic, we recovered phages infecting a Vi-deficient S. Typhi strain from 41 samples (29%). All 41 phages also infected the isogenic Vi-expressing host, although 28 did so with 10- to 10⁵-fold lower infection efficiency, and suppressing capsule expression increased susceptibility to 23, indicating an inhibitory effect of Vi on infection by many these phages. All 41 phages infected S. Paratyphi A and nine infected a monophasic S. Typhimurium, a broader host range than the Vi-dependent phages, which were restricted to Vi-expressing Typhi. Across 26 circulating genotypes, capsule suppression increased susceptible genotypes per phage by 1.51 on average (Wilcoxon p = 5.76 × 10⁻⁶), though four genotypes remained resistant to all phages tested, indicating additional determinants of susceptibility. Whole-genome sequencing of 27 phages identified three genera in two families, predominantly Teetrevirus (19/27); TerL phylogeny separated these from classical Vi-dependent phage lineages. Together, these findings reveal a broader-host-range component of Typhi phage ecology and show that Vi dependence is not a universal feature of phages capable of infecting S. Typhi. Importance: The Vi capsule is a defining surface antigen of Salmonella Typhi and is required for infection by characterized Typhi phages. Here, we show that this dependence is not universal. In a typhoid-endemic setting, we identified environmental phages capable of infecting S. Typhi in the absence of Vi, revealing a previously underrecognized infection strategy. These Vi-independent phages showed broader host ranges than classical Vi-dependent phages, with susceptibility varying across S. Typhi lineages. Genomic characterization identified that these phages were from lineages distinct from Vi-dependent phages. Together, these findings reveal greater diversity in S. Typhi-phage interactions than previously appreciated and suggest that Vi-dependent specialists represent only one component of a broader Typhi-phage ecological landscape. As these phages were identified before the national introduction of the Vi-typhoid conjugate vaccine, they also provide a baseline for future studies examining whether population-level targeting of the Vi capsule is accompanied by changes in Typhi-phage ecology.

  • Open Access

    Escalating burden and mortality of carbapenem-resistant Klebsiella pneumoniae species complex infections in Bangladeshi infants

    by Yogesh Hooda, Arif Mohammad Tanmoy, Naito Kanon, Hafizur Rahman, Mohammad Shahidul Islam, Zabed Bin Ahmed, Afroza Akter Tanni, Md Mobarok Hossain, Md Hasanuzzaman, Sharmistha Goswami, et al.

    Klebsiella pneumoniae infections in young infants are an escalating threat in low- and middle-income countries, yet robust longitudinal data integrating hospital burden, clinical outcomes, antimicrobial resistance, and genomics remains scarce. We performed an 18-year (2004–2021) prospective, multicenter genomic epidemiology study across four hospitals in Bangladesh. Among 122,353 enrolled children from whom blood and/or cerebrospinal fluid cultures were performed, 1600 (1.3%) yielded culture-confirmed Klebsiella pneumoniae species complex (KpSC) isolates. Positivity increased from 16 per 1000 cases tested in 2004 to 37 per 1000 in 2021. Hospital case-fatality rate (CFR) rose from 21.4% to 51.4% during the study, paralleling the emergence and expansion of carbapenem resistance, first detected in 2008 and reaching 81% of isolates by 2021. Neonates accounted for 80.5% of infections and experienced a CFR of 40.8%. Whole-genome sequencing of 599 representative isolates revealed four KpSC species, 145 sequence types, and 92 capsular alleles. Global high-risk clones ST11, ST16, and ST147 harbouring NDM-type carbapenemases dominated recent cases. These findings document the increasing resistance and mortality associated with KpSC infections amongst neonates in Bangladesh, underscoring the urgent need for strengthened infection prevention and control, equitable access to effective combination therapies, and vaccine-based preventative strategies.


  • Open Access

    Integrating patient movement and pathogen genomics to support hospital infection prevention with PathoPath: a method development study

    by Mohammad Si Sajib, Arif M Tanmoy, Naito Kanon, Anannya Barman Jui, Mohammad Shahidul Islam, Nigha Z Dola, Mohammad M Hossain, Reaz Mobarak, Mohammad Shahidullah, Mahbubul Hoque, et al.

    Summary: Background: Healthcare-associated infections pose a major burden to neonatal health worldwide and remain difficult to track in low-resource hospitals because patient movement data and pathogen genomic data are rarely integrated into actionable transmission models. Existing approaches are often restricted to specific settings, highly structured electronic health records (EHRs), or analyses focused on either patient movements or pathogen characteristics alone. To address this gap, we developed PathoPath, an open-source integrative modelling platform, and evaluated its utility in a high burden paediatric hospital in Dhaka, Bangladesh. Methods: PathoPath is an open-source R package that combines electronic health records with whole genome sequencing data to generate contact networks from direct and indirect contacts using minimal structured inputs. We retrospectively applied PathoPath to 373 cases of Klebsiella pneumoniae species complex (KpSC) infection identified in 2021 at the largest paediatric referral hospital in Dhaka, Bangladesh. Ward level patient movement trajectories were used to reconstruct contact networks, and genomic data from isolates from children Klebsiella pneumoniae species complex (KpSC) infection at Bangladesh Shishu Hospital and Institute (BSHI), the largest tertiary paediatric healthcare facility in Dhaka which serves as a referral centre in Bangladesh for the sick paediatric population. Using PathoPath, we successfully identified sustained K. pneumoniae ST147 clonal transmission and a few events of potential dissemination of carbapenemase-encoding plasmids among K. pneumoniae ST16, providing us a better understanding on how resistance is moving through the hospital network. Implications of all the available evidence: PathoPath provides a scalable approach to generate high resolution data to inform infection prevention and control in settings that still lack well-defined electronic healthcare records. This could provide a greater level of understanding of transmission than that offered by standard practice and enable the implementation of targeted, cost-effective interventions to prevent further outbreaks or spread of antimicrobial resistance within hospitals.

  • Open Access

    Unique nasal cell states induced by common pediatric respiratory viruses

    by Jaclyn M. L. Walsh, Lillian J. Juttukonda, Ying Tang, Ankita Chatterjee, Marc Elosua-Bayes, Erica Langan, Amanda Frischmann, Faith Taliaferro, Hannah R. Matthews, Kyle Kimler, et al.

    Summary: Respiratory viral infections in early childhood are major drivers of acute morbidity and long-term airway disease, yet how distinct viruses remodel the pediatric nasal mucosa at cellular resolution remains unresolved. Here, we generated a single-cell RNA sequencing atlas of 335,174 nasal epithelial and immune cells from 132 children under five years of age with SARS-CoV-2, rhinovirus, or respiratory syncytial virus (RSV) infection, alongside uninfected controls. Mapping viral transcripts to individual cells revealed virus-specific infected epithelial states: an NF-kB-responsive ciliated subset in SARS-CoV-2 and a previously undescribed KRT17+ squamous-like subset in RSV. We delineated divergent mucosal response programs, including a robust interferon (IFN) response in SARS-CoV-2, an IL-13-responsive secretory program in rhinovirus, and heightened inflammatory and cytotoxic immune activation in RSV. In RSV, specific immune subsets and elevated IFN-response signatures were associated with disease severity, whereas rhinovirus-induced wheeze was marked by expansion of a CST1 + goblet cell subset. Integration of asthma genome-wide association data with our atlas revealed a KRT13+ hillock-like squamous epithelial subset enriched for expression of childhood-onset asthma risk loci. Finally, we demonstrate that this resource enables high-resolution annotation of independent pediatric cohorts in Kolkata, India and rural Bangladesh. Together, this atlas establishes a comprehensive view of antiviral immunity in the pediatric nasal mucosa and defines virus-specific mucosal immune programs relevant to disease severity and asthma risk in early life.

  • Open Access

    A low-cost rpoB -based multiplex MAMA PCR for differentiation of the Klebsiella pneumoniae species complex

    by Mehbooba Sharmin, Al Amin, Hafizur Rahman, Nicol Janecko, Samir K Saha, Yogesh Hooda, Arif Mohammad Tanmoy, Senjuti Saha

    The Klebsiella pneumoniae species complex (KpSC) is a clinically important group of closely related pathogens associated with invasive infections. The complex comprises seven closely related members, which are often reported as K. pneumoniae , particularly in resource-limited settings. Accurate differentiation of KpSC members remains challenging because routine laboratory methods lack sufficient resolution, and approaches like mass spectrometry and whole genome sequencing (WGS) are not widely available. Consequently, the epidemiology and clinical significance of non- K. pneumoniae members of the KpSC remain underrecognized. We developed a conventional multiplex mismatch amplification mutation assay (MAMA) PCR targeting species- and subspecies-specific single-nucleotide polymorphisms in the housekeeping gene rpoB , with six primer sets for differentiation of common KpSC members. The assay was validated against 49 genomically characterized clinical isolates, after which 179 wastewater-derived isolates provisionally identified as Klebsiella spp. by standard microbiological methods were tested. Of these, 174 were assigned to specific KpSC members by the assay, while 5 produced inconclusive amplification patterns. A subset of 16 environmental isolates was selected for WGS, including four of the five inconclusive isolates. All environmental isolates with interpretable MAMA PCR patterns were concordant with WGS. The four inconclusive environmental isolates were identified as Enterobacter spp. Overall, comparison of MAMA PCR with WGS showed 100% sensitivity and 100% specificity for all tested targets, and the total cost was approximately US$1. This rpoB -based multiplex MAMA PCR provides a simple, accurate, and low-cost approach for differentiation of KpSC members in routine laboratories and may support improved identification and surveillance in resource-limited settings. Importance: The Klebsiella pneumoniae species complex (KpSC) has seven members but is often reported as a single organism in routine laboratories, masking clinically and epidemiologically important diversity. As a result, the contribution of non- K. pneumoniae KpSC members to human and environmental microbiology remains poorly defined, especially in low-resource settings. We developed a conventional multiplex mismatch amplification mutation assay (MAMA) PCR based on discriminatory rpoB single nucleotide polymorphisms for differentiation of common KpSC members using standard PCR and agarose gel electrophoresis. The assay demonstrated 100% sensitivity and 100% specificity against whole-genome sequencing and excluded non- Klebsiella environmental isolates initially identified as Klebsiella pneumoniae using standard microbiological procedures. With an estimated per-test cost of about US$1, this method offers an affordable and scalable option for laboratories seeking more accurate KpSC identification and improved surveillance.

  • Open Access

    Neuroinvasive Human Parvovirus 4 is associated with increased mortality in children: a multiyear retrospective observational study

    by Deb Purna Keya, Apurba Rajib Malaker, Naito Kanon, Arif Mohammad Tanmoy, Saffat Reaz, Preonath Chondrow Dev, Hafizur Rahman, Lubana Tanvia, Anisur Rahman, Afroza Akter Tanni, et al.

    Background: Infections of the central nervous system (CNS) in children remain a major cause of mortality and long-term disability globally, particularly in low- and middle-income countries (LMICs), where a high proportion of cases lack an identified pathogen. Sporadically, human parvovirus 4 (PARV4) has been detected in a small number of cerebrospinal fluid (CSF) from children with CNS infections, but its pathogenic role is unclear. We investigated the prevalence, clinical impact, and genomic characteristics of PARV4 in children with suspected meningitis. Methods: We retrospectively analyzed CSF samples collected from children with WHO-defined suspected meningitis at the largest pediatric hospital in Bangladesh between 2015-2022. All samples underwent routine diagnostics, including bacterial culture and serological testing. Additional testing for PARV4 and parvovirus B19 was performed using qPCR of samples with >9 white blood cell (WBC)/µl followed by metagenomic sequencing of a subset. Clinical and laboratory data were extracted from patient records. Associations between PARV4 detection and mortality were assessed using logistic regression, adjusting for age, WBC count, and co-infections. Genomic and phylogenetic analyses were conducted on PARV4-positive samples. Findings: Among 2,793 CSF samples with >9 WBC/µl, 526 (18·8%) were PARV4-positive. The median age of PARV4-positive cases was lower than that of PARV4-negative cases (4 vs 7 months, p<0·001). Co-infections were more common among PARV4-positive cases (49·6%) than PARV4-negative cases (16·4%). PARV4 positivity was independently associated with increased in-hospital mortality (adjusted odds ratio 2·09, 95%CI:1·46–2·96; p<0·001). Phylogenetic analysis indicated most strains belonged to genotype 2, with two sequences forming a distinct clade. Interpretation: PARV4 is frequently detected in the CSF of children with suspected meningitis and is associated with increased in-hospital mortality. Its high prevalence, detection early in life, and frequent co-infection with other pathogens highlight the need to investigate PARV4 as an emerging CNS pathogen in LMICs.

  • Open Access

    Reemergence and global distribution of an invasive lineage of Streptococcus pneumoniae serotype 2

    by Yogesh Hooda, Arif Mohammad Tanmoy, Krishna Banik Pushpita, Naito Kanon, Hafizur Rahman, Hakka Naziat, Harry C H Hung, Roly Malaker, Hasanuzzaman, Apurba Rajib Malaker, et al.

    Streptococcus pneumoniae is a leading cause of childhood meningitis, sepsis and pneumonia despite widespread implementation of pneumococcal conjugate vaccines (PCVs). Serotype 2, once a major invasive serotype that nearly disappeared in the mid-20th century, is not included in current vaccine formulations. Recent reports from multiple countries suggest potential re-emergence of serotype 2. Here, we present 30 years of hospital-based surveillance from Bangladesh (1993-2022), where serotype 2 accounted for 7.8% of invasive pneumococcal disease cases. Infections occurred predominantly in very young infants (median age, 3 months) and were largely associated with meningitis (91.3%), with nearly 90% of isolates recovered from cerebrospinal fluid. Comparative analysis of otitis media and nasopharyngeal carriage isolates demonstrated high invasive propensity relative to other serotypes. Whole genome sequencing of 170 serotype 2 isolates from 21 countries revealed that all modern isolates belong to the globally disseminated lineage GPSC96, which is distinct from the prototypical laboratory strain D39 (GPSC622). Phylodynamic reconstruction dated the emergence of GPSC96 to the late 19th century, with continued global circulation and largely preserved antibiotic susceptibility. These findings highlight serotype 2 as a potential invasive pneumococcal threat in countries such as Bangladesh and supports consideration of its inclusion in the next-generation conjugate vaccines.

  • Cohort Profile: Health and Demographic Surveillance System in Mirzapur, Tangail, Bangladesh

    by Senjuti Saha, Naito Kanon, Mohammad Shahidul Islam, Mohammad Shameem Hassan, Yogesh Hooda, Lubana Tanvia, Qazi Sadeq-Ur Rahman, Rajib C Das, Shampa Saha, Sanwarul Bari, et al.


  • Open Access

    Escalating burden and mortality of carbapenem-resistant Klebsiella pneumoniae species complex infections in Bangladeshi infants

    by Yogesh Hooda, Arif Mohammad Tanmoy, Naito Kanon, Hafizur Rahman, Mohammad Shahidul Islam, Zabed Bin Ahmed, Afroza Akter Tanni, Mobarok Hossain, Hasanuzzaman, Sharmistha Goswami, et al.

    Klebsiella pneumoniae infections in young infants are an escalating threat in low- and middle-income countries, yet robust longitudinal data integrating hospital burden, clinical outcomes, antimicrobial, and genomics remains scarce. We performed an 18-year (2004-2021) prospective, multicenter genomic epidemiology study across four hospitals in Bangladesh. Among 122,353 enrolled children from whom blood or cerebrospinal fluid cultures were performed, 1,600 (1.3%) yielded culture-confirmed Klebsiella pneumoniae species complex (KpSC) isolates. Positivity increased from 16 per 1,000 cases tested in 2004 to 37 per 1,000 in 2021. Hospital case-fatality rate (CFR) rose from 21.4% to 51.4% during the study, paralleling the emergence and expansion of carbapenem resistance, first detected in 2008 and reaching 81% of isolates by 2021. Neonates accounted for 80.5% of infections and experienced a CFR of 40.8%. Whole-genome sequencing of 599 representative isolates revealed four KpSC species, 145 sequence types and 92 capsular alleles. Global high-risk clones ST11, ST16 and ST147 harbouring NDM-type carbapenemases dominated recent cases. These findings document the increasing resistance and mortality associated with KpSC infections amongst neonates in Bangladesh, underscoring the urgent need for strengthened infection prevention & control, equitable access to effective combination therapies, and vaccine-based preventative strategies.


  • Impact of 10-valent pneumococcal conjugate vaccine on the epidemiology of otitis media with otorrhea among Bangladeshi children

    by Hakka Naziat, Hafizur Rahman, Rajib C. Das, Maksuda Islam, Shampa Saha, Manzoor Hussain, Asif Sattar, Mohammad J. Uddin, Jahangir Alam, Cynthia G. Whitney, et al.